EW saw its Momentum Indicator move above the 0 level on October 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned positive. In 60 of the 88 cases, the stock moved higher in the following days. The odds of a move higher are at 68%.
The Moving Average Convergence Divergence (MACD) for EW just turned positive on October 14, 2026. Looking at past instances where EW's MACD turned positive, the stock continued to rise in 25 of 43 cases over the following month. The odds of a continued upward trend are 58%.
EW moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where EW advanced for three days, in 170 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
EW broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for EW entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 33 (best 1 - 100 worst), indicating outstanding price growth. EW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 72 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.891) is normal, around the industry mean (2.874). P/E Ratio (51.776) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (1.852) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (7.974) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
RULE's Aroon Indicator triggered a bullish signal on October 14, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 254 similar instances where the Aroon Indicator showed a similar pattern. In 199 of the 254 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 78%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RULE's RSI Oscillator exited the oversold zone, 18 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 55%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where RULE advanced for three days, in 205 of 289 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
RULE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RULE as a result. In 64 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.
The Moving Average Convergence Divergence Histogram (MACD) for RULE turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 34 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 63%.
RULE moved below its 50-day moving average on October 15, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for RULE crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RULE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
EW | ||
|---|---|---|
OUTLOOK RATING 1..100 | 19 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 72 | |
PRICE GROWTH RATING 1..100 | 33 | |
P/E GROWTH RATING 1..100 | 8 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| EW | RULE | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 55% |
| Stochastic ODDS (%) | 2 days ago 64% | 2 days ago 74% |
| Momentum ODDS (%) | 2 days ago 68% | 2 days ago 69% |
| MACD ODDS (%) | 2 days ago 58% | 2 days ago 63% |
| TrendWeek ODDS (%) | 2 days ago 60% | 2 days ago 72% |
| TrendMonth ODDS (%) | 2 days ago 55% | 2 days ago 74% |
| Advances ODDS (%) | 2 days ago 58% | 3 days ago 71% |
| Declines ODDS (%) | 16 days ago 60% | 8 days ago 69% |
| BollingerBands ODDS (%) | 2 days ago 71% | 2 days ago 69% |
| Aroon ODDS (%) | 2 days ago 76% | 2 days ago 78% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EW’s FA Score shows that 2 FA rating(s) are green while .
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EW’s TA Score shows that 4 TA indicator(s) are bullish.
EW (@Medical/Nursing Services) experienced а +2.26% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.53%. For the same industry, the average monthly price growth was -9.75%, and the average quarterly price growth was -10.71%.
EW is expected to report earnings on Nov 04, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor tells us that RULE and NWE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RULE and NWE's prices will move in lockstep.
| Ticker / NAME | Correlation To RULE | 1D Price Change % | ||
|---|---|---|---|---|
| RULE | 100% | -2.90% | ||
| NWE - RULE | 30% Poorly correlated | +1.35% | ||
| ETN - RULE | 20% Poorly correlated | -6.33% | ||
| EW - RULE | 19% Poorly correlated | +1.91% | ||
| CNS - RULE | 17% Poorly correlated | +2.58% | ||
| MS - RULE | 16% Poorly correlated | -1.63% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CURE | 159.07 | 6.06 | +3.96% |
| Direxion Daily Healthcare Bull 3X ETF (CURE) | |||
| INVN | 27.68 | 0.38 | +1.40% |
| Alger Russell Innovation ETF (INVN) | |||
| IGR | 10.70 | 0.04 | +0.38% |
| CBRE Global Real Estate Income Fund | |||
| ADIV | 19.19 | -0.20 | -1.03% |
| Guinness Atkinson Asia Pacific Dividend Builder ETF (ADIV) | |||
| CEF | 38.92 | -1.63 | -4.02% |
| Sprott Physical Gold and Silver Trust | |||